Rchr
J-GLOBAL ID:201001056555169072   Update date: Apr. 13, 2021

Ishiyama Ken

イシヤマ ケン | Ishiyama Ken
Affiliation and department:
Research field  (1): Hematology and oncology
Papers (106):
  • Takeshi Yoroidaka, Kohei Hosokawa, Tatsuya Imi, Hiroki Mizumaki, Takamasa Katagiri, Ken Ishiyama, Hirohito Yamazaki, Fumihiro Azuma, Yasuhito Nanya, Seishi Ogawa, et al. Hematopoietic stem progenitor cells lacking HLA differ from those lacking GPI-anchored proteins in the hierarchical stage and sensitivity to immune attack in patients with acquired aplastic anemia. Leukemia. 2021
  • Kohei Hosokawa, Hiroki Mizumaki, Takeshi Yoroidaka, Hiroyuki Maruyama, Tatsuya Imi, Noriaki Tsuji, Ryota Urushihara, Mikoto Tanabe, Yoshitaka Zaimoku, Mai Anh Thi Nguyen, et al. HLA class I allele-lacking leukocytes predict rare clonal evolution to MDS/AML in patients with acquired aplastic anemia. Blood. 2021
  • Keiko Ogawa-Ochiai, Takamasa Katagiri, Yuki Sato, Akiko Shirai, Ken Ishiyama, Akiyoshi Takami, Eriko Morishita. Natural killer cell function changes by the Japanese Kampo Medicine Juzentaihoto in General fatigue patients: an open label study. ADVANCES IN INTEGRATIVE MEDICINE. 2021. 8. 1. 33-43
  • Kohei Hosokawa, Go Aoki, Kinya Ohata, Hiroyuki Takamatsu, Noriharu Nakagawa, Tatsuya Imi, Noriko Iwaki, Kiyoaki Ito, Mitsuhiro Kawano, Takashi Nakamura, et al. Effectiveness of hyperbaric oxygen therapy for virus-associated hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation. INTERNATIONAL JOURNAL OF HEMATOLOGY. 2021
  • Takaaki Konuma, Ken Ishiyama, Aiko Igarashi, Naoyuki Uchida, Yukiyasu Ozawa, Takahiro Fukuda, Yasunori Ueda, Ken-ichi Matsuoka, Takehiko Mori, Yuta Katayama, et al. Effects of Acute and Chronic Graft-versus-myelodysplastic Syndrome on Long-term Outcomes Following Allogeneic Hematopoietic Cell Transplantation. CLINICAL CANCER RESEARCH. 2020. 26. 24. 6483-6493
more...
MISC (200):
  • 輿石 晴也, 高橋 英介, 和田 良樹, 吉村 哲規, 青木 淳, 石山 謙, 宮脇 修一, 加藤 弘之, 江花 弘基. 多発嚢胞性病変を示した肺軽鎖沈着症(Pulmonary Light Chain Deposition Disease:LCDD)の1例. 癌と化学療法. 2020. 47. 13. 1997-1999
  • 黒澤修兵, 下村良充, 立花崇孝, 石山謙, 太田秀一, 小林武, 内田直之, 福島健太郎, 諫田淳也, 一戸辰夫, et al. Outcomes of allogeneic hematopoietic stem cell transplantation in patients with MDS/MPN-U. 日本造血細胞移植学会総会プログラム・抄録集. 2020. 42nd
  • 青木淳, 青木一成, 小沼貴晶, 土岐典子, 片山雄太, 内田直之, 澤正史, 鬼塚真仁, 松岡賢市, 神田善伸, et al. Impact of azacitidine pretreatment on outcomes of allo-HSCT in patients with high-risk MDS. 日本造血細胞移植学会総会プログラム・抄録集. 2020. 42nd
  • 水牧裕希, 岩城憲子, 数本弘子, 近川由衣, 井美達也, 荒幡昌久, 高松博幸, 石山謙, 山崎宏人, 山崎宏人, et al. Favorable response to the second mesenchymal stem cell therapy for hyperacute GVHD in a patient with peripheral T cell lymphoma. 日本造血細胞移植学会総会プログラム・抄録集. 2020. 42nd
  • 近川由衣, 貫井友貴, 漆原涼太, 辻紀章, 田辺命, 水牧裕希, 荒幡昌久, 井美達也, 岩城憲子, 細川晃平, et al. Ara-C/ACR therapy for MDS patients with complex karyotype including del(5q) refractory to azacitidine; potential bridging for allo-HCT. 日本造血細胞移植学会総会プログラム・抄録集. 2020. 42nd
more...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page